ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 347 filers reported holding ISIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $22,579,000 | -30.0% | 558,607 | -0.3% | 0.01% | -22.2% |
| Q2 2015 | $32,242,000 | -34.3% | 560,228 | -27.3% | 0.01% | -30.8% |
| Q1 2015 | $49,040,000 | +11.2% | 770,229 | +7.8% | 0.01% | +8.3% |
| Q4 2014 | $44,110,000 | +56.3% | 714,450 | -1.7% | 0.01% | +50.0% |
| Q3 2014 | $28,217,000 | -43.8% | 726,675 | -50.2% | 0.01% | +14.3% |
| Q2 2014 | $50,250,000 | +72.6% | 1,458,666 | +116.5% | 0.01% | -12.5% |
| Q1 2014 | $29,111,000 | +12.0% | 673,705 | +3.2% | 0.01% | +14.3% |
| Q4 2013 | $26,002,000 | -47.0% | 652,662 | -50.0% | 0.01% | 0.0% |
| Q3 2013 | $49,038,000 | +178.8% | 1,306,330 | +99.5% | 0.01% | +16.7% |
| Q2 2013 | $17,591,000 | – | 654,705 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |